Menu
Back to User profile » Dr Ta-Sen Yeh
Papers published by Dr Ta-Sen Yeh:
Metabolism of Proteins and Amino Acids in Critical Illness: From Physiological Alterations to Relevant Clinical Practice
Hsu CC, Sun CY, Tsai CY, Chen MY, Wang SY, Hsu JT, Yeh CN, Yeh TS
Journal of Multidisciplinary Healthcare 2021, 14:1107-1117
Published Date: 14 May 2021
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Chiang K, Huang S, Wu RC, Huang SC, Yeh T, Chen M, Hsu JT, Chen L, Kuo SF, Chueh H, Juang H, Hung S, Yeh C, Pang JS
Cancer Management and Research 2019, 11:1893-1905
Published Date: 28 February 2019
HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
Yeh CN, Wu RC, Cheng CT, Tsai CY, Chang YR, Yeh TS, Wu TH, Lee WC, Chiang KC
Cancer Management and Research 2018, 10:6049-6059
Published Date: 21 November 2018
PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo
Chiang KC, Chen HY, Hsu SY, Pang JHS, Wang SY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Sun CC, Lee JM, Yeh CN, Juang HH
Drug Design, Development and Therapy 2015, 9:4631-4638
Published Date: 13 August 2015
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS
OncoTargets and Therapy 2015, 8:1899-1907
Published Date: 28 July 2015
Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
Yeh CN, Hsieh FJ, Chiang KC, Chen JS, Yeh TS, Jan YY, Chen MF
Drug Design, Development and Therapy 2015, 9:163-174
Published Date: 17 December 2014